Theophylline (Cyrano Therapeutics)

N/A

Report date: 2023/01/19 15:04:49

Base Information

Drug NameTheophylline (Cyrano Therapeutics)
Drug Alias NameCYR-064
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine receptor antagonistsPhosphoric diester hydrolases inhibitors
TargetsAdenosine receptorPhosphoric diester hydrolases
Therapy Area/IndicationsOlfaction Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesUniversity of Nebraska
Active IndicationsOlfaction Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A